Frazier Life Sciences Management, L.P.

13F Filings History

Latest 13F report: Q4 2024 - Feb 18, 2025
Value $: $2.41B
Signature - Title: Steve R. Bailey - Chief Financial Officer and Chief Compliance Officer
Location: Palo Alto, CA
Summary: This page shows a list of all the recent 13F filings made by Frazier Life Sciences Management, L.P.. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Frazier Life Sciences Management, L.P. reported 50 stock holdings with total value $2.41B as of Q4 2024. Top holdings included NAMS, MIRM, VRNA, KRYS, and ARQT.

Holdings Value

Quarter	Holdings	Value $	Bought	Sold	Net	Top Holdings	Form Type	Date Filed
Q4 2024	50	$2.41B	+$144M	-$186M	-$42.6M	NAMS, MIRM, VRNA, KRYS, ARQT	13F-HR	2/14/2025, 06:44 PM
Q3 2024	53	$2.5B	+$288M	-$85.1M	+$203M	MIRM, NAMS, PHAT, KRYS, MBX	13F-HR	11/15/2024, 07:41 AM
Q2 2024	49	$2.14B	+$257M	-$322M	-$65.5M	NAMS, MIRM, KRYS, HLVX, PHAT	13F-HR	8/15/2024, 12:49 PM
Q1 2024	49	$2.37B	+$230M	-$107M	+$123M	NAMS, KRYS, MIRM, HLVX, ALPN	13F-HR	5/15/2024, 12:00 PM
Q4 2023	49	$1.87B	+$156M	-$83.8M	+$71.8M	MIRM, HLVX, NAMS, KRYS, BBIO	13F-HR	2/14/2024, 01:55 PM
Q3 2023	54	$1.5B	+$238M	-$250M	-$11.6M	MIRM, HLVX, KRYS, NAMS, PHAT	13F-HR	11/14/2023, 01:40 PM
Q2 2023	53	$1.67B	+$153M	-$80.1M	+$72.6M	HLVX, KDNY, PHAT, NAMS, KRYS	13F-HR	8/14/2023, 10:48 AM
Q1 2023	49	$1.38B	+$109M	-$25.3M	+$83.3M	HLVX, NAMS, KDNY, ARQT, MIRM	13F-HR	5/15/2023, 12:41 PM
Q4 2022	44	$1.61B	+$227M	-$11M	+$216M	HLVX, IMGO, ARQT, KDNY, NAMS	Restatement	2/7/2023, 01:30 PM
Q3 2022	42	$1.27B	+$201M	-$14.1M	+$187M	HLVX, ARQT, PHAT, KDNY, SNDX	13F-HR	11/14/2022, 09:29 AM
Q2 2022	41	$1.06B	+$148M	-$144M	+$4.51M	ARQT, HLVX, KRYS, MIRM, KDNY	13F-HR	8/10/2022, 03:07 PM
Q1 2022	42	$1.17B				ARQT, PHAT, MIRM, SRRA, KRYS	13F-HR	5/13/2022, 07:15 PM